Respiratorius AB (XSAT:RESP) Other Current Receivables : kr0.33 Mil (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Other Current Receivables?

Respiratorius AB's Other Current Receivables for the quarter that ended in Dec. 2024 was kr0.33 Mil.

Respiratorius AB's quarterly Other Current Receivables stayed the same from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr0.00 Mil) but then increased from Sep. 2024 (kr0.00 Mil) to Dec. 2024 (kr0.33 Mil).

Respiratorius AB's annual Other Current Receivables declined from Dec. 2022 (kr0.69 Mil) to Dec. 2023 (kr0.25 Mil) but then increased from Dec. 2023 (kr0.25 Mil) to Dec. 2024 (kr0.33 Mil).

Respiratorius AB Other Current Receivables Historical Data

The historical data trend for Respiratorius AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Other Current Receivables Chart

Respiratorius AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

1.04

0.89

0.69

0.25

0.33

Respiratorius AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Apr22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Receivables	Get a 7-Day Free Trial															0.25	-	-	-	0.33

Respiratorius AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Respiratorius AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiratorius AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

https://www.respiratorius.com

Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines